| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IGHE |
P01854
|
immunoglobulin heavy constant epsilon
|
|
|
0.626 |
0.538 |
| IGHG3 |
P01860
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
|
0.513 |
0.769 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| THM |
|
thymoma
|
|
|
0.686 |
0.500 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| DEFB103B |
P81534
|
defensin beta 103B
|
|
|
0.572 |
0.731 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| IRGM |
A1A4Y4
|
immunity related GTPase M
|
|
|
0.617 |
0.538 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR140 |
|
microRNA 140
|
|
|
0.522 |
0.769 |